Abstract
Methamphetamine use has recently increased to epidemic proportions in California. In fiscal year 1995, almost 20,000 drug treatment clients reported methamphetamine as primary drug. Of these clients, about one in five reported injection as primary route of administration. This paper identifies correlates of injection among methamphetamine users in order to assist in targeting HIV prevention efforts. Clients reporting methamphetamine as primary drug were selected from the California Alcohol and Drug Data System for analysis. Descriptive statistics were compiled and a logistic regression was conducted to identify correlates of injection use. Latino and African-American methamphetamine users were less likely than White methamphetamine users to report injection as primary route of administration; males were more likely than females. Clients were more likely to report injection use with increasing age. Current heroin use and residence in an urban area were also related to injection status. In conclusion, California is home to a large number of methamphetamine users, a significant portion of whom inject. Data on this population are limited; needle sharing, cleaning of injection equipment, and sexual risk behaviors among this population should be closely studied. Treatment programs targeting methamphetamine users should include comprehensive HIV prevention components.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Anglin, M., Kalechstein, A., Maglione, M., Annon, J., and Fiorentine, R. (1997). Methamphetamine abuse and treatment in California: A regional report. Los Angeles, CA: UCLA Drug Abuse Research Center.
Battjes, R. J., Pickens, R. W., and Brown, L. S., Jr. (1995). HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: An update. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 90–96.
Cannon, S. (1996). Methamphetamine—A growing threat to California. Sacramento, CA: Department of Alcohol and Drug Programs.
Centers for Disease Control. (1995). Increasing morbidity and mortality associated with abuse of methamphetamine—United States, 1991–1994. Morbidity and Mortality Weekly Report, 44, 882–886.
Cunningham, J. K., and Thielemier, M. A. (1995). Trends in regional variations in amphetamine-related emergency admissions: California, 1984–1993. Irvine, CA: Public Statistics Institute.
Des Jarlais, D. C., and Friedman, S. R. (1987). HIV infection among intravenous drug users: Epidemiology and risk reduction. AIDS, 1, 67–76.
Eggan, F., Reback, C. J., and Ditman, D. (1996, July). Methamphetamine use among gay male drug users: An ethnographic study. Paper presented at the XI International Conference on AIDS, Vancouver, Canada.
Hong, R., Matsuyama, E., and Nur, K. (1991). Cardiomyopathy associated with the smoking of crystal methamphetamine. Journal of the American Medical Association, 265, 1152–1154.
Hunter, G. M., Donoghoe, M. C., Stimson, G. V., Rhodes, T., and Chalmers, C. P. (1995). Changes in the injecting risk behaviour of injecting drug users in London, 1990–1993. AIDS, 9, 493–501.
Longshore, D., Anglin, M. D., Annon, K., and Hsieh, S. (1993). Trends in self-reported HIV risk behavior: Injection drug users in Los Angeles. Journal of Acquired Immune Deficiency Syndromes, 6, 82–90.
National Methamphetamine strategy. (1996). Washington, DC: U.S. Department of Justice, Office of the Attorney General.
Office of National Drug Control Policy. (1996). National drug control strategy. Washington, DC: The White House.
Reback, C. J. (1996, June). HIV risk factors among gay/bisexual/lesbian and transgender street users. Paper presented at the 58th Annual Meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico.
Rhodes, T., Donoghoe, M. C., Hunter, G., Soteri, A., and Stimson, G. V. (1994). Sexual behaviour of drug injectors in London: Implications for HIV transmission and HIV prevention. Addiction, 89, 1085–1096.
Schoenbaum, E. E., Hartel, D., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., Feiner, C., and Friedland, G. (1989). Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine, 321, 874–879.
Stephens, R. C., Feucht, T. E., and Gibbs, B. H. (1993). Needle use behavior. In B. S. Brown and G. M. Beschner (Eds.), Handbook on risk of AIDS: Injection drug users and sexual partners (pp. 116–136). Westport, CT: Greenwood Press.
Trotter, R., Bowen, A., Baldwin, J., and Price, L. (1996). The efficacy of network-based HIV/AIDS risk reduction programs in midsized towns in the United States. Journal of Drug Issues, 26, 591–605.
Watters, J. K. (1994). Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986–1992. Journal of Acquired Immune Deficiency Syndromes, 7, 1276–1281.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maglione, M., Chao, B. & Anglin, M.D. Methamphetamine Abuse in California: Correlates of Injection Use. AIDS Behav 2, 257–261 (1998). https://doi.org/10.1023/A:1022193902842
Issue Date:
DOI: https://doi.org/10.1023/A:1022193902842